Pfizer Inc. Revenue 2007–2025
Pfizer Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pfizer Inc. revenue for the quarter ending March 29, 2026 was 14.5 B, a 5.37% increase year-over-year.
- Pfizer Inc. revenue for the twelve months ending March 29, 2026 was 59.5 B, a 0.20% increase year-over-year.
- Pfizer Inc. annual revenue for 2025 was 62.6 B, a 1.65% decrease from 2024.
- Pfizer Inc. annual revenue for 2024 was 63.6 B, a 24.97% increase from 2023.
- Pfizer Inc. annual revenue for 2023 was 50.9 B, a 44.53% decrease from 2022.
- Pfizer Inc. annual revenue for 2022 was 91.8 B.
Pfizer Inc. (PFE) — Frequently Asked Questions
Pfizer Inc. (PFE) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $146.25B. In fiscal 2025 it reported revenue of $62.58B and net income of $7.77B. Explore PFE's stock price, financial statements, earnings history, margins and key ratios below.
What is Pfizer Inc.'s market cap?
Pfizer Inc. (PFE) has a market capitalization of $146.25B.
What is the PFE stock price?
PFE trades at $25.60 (-0.39% on the day).
How much revenue does Pfizer Inc. make?
Pfizer Inc. reported revenue of $62.58B in fiscal 2025.
Is PFE profitable?
In fiscal 2025, Pfizer Inc. reported net income of $7.77B.
What is PFE's P/E ratio?
Based on diluted EPS, PFE has a price-to-earnings (P/E) ratio of about 18.8.